RADIUM REVISITED: CLINICAL EXPERIENCES WITH A NOVEL ALPHA-EMITTING BONE-SEEKING RADIOPHARMACEUTICAL IN PATIENTS WITH SKELETAL METASTASES FROM PROSTATE AND BREAST CANCER

被引：0
|
作者：
Nilsson, S. [1 ]
Larsen, R. H. [2 ]
Bruland, O. S. [3 ]
机构：
[1] Karolinska Hosp, S-10401 Stockholm, Sweden
[2] Algeta Inc, Oslo, Norway
[3] Norwegian Radium Hosp, Oslo, Norway
来源：
ANTICANCER RESEARCH | 2004年 / 24卷 / 5D期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3445 / 3446
页数：2
相关论文
共 50 条
  • [1] Clinical experiences using radium-223, a novel α-emitting bone-seeking radiopharmaceutical, in breast and prostate cancer patients with skeletal metastases
    Nilsson, S
    Larsen, RH
    Bruland, OS
    CANCER TREATMENT REVIEWS, 2005, 31 : S30 - S31
  • [2] Bone-seeking radiopharmaceuticals in patients with skeletal metastases. Clinical experience using alpha-emitting radium-223
    Nilsson, S.
    Larsen, R. H.
    Bruland, O. S.
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 : S23 - S24
  • [3] Alpha particle-emitting radium-223: A promising bone-seeking radiopharmaceutical product for the treatment of skeletal metastases
    Bruland, OS
    Nilsson, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1587 - 1587
  • [4] Phase I study of Alpharadin™ (223Ra), an alpha-emitting bone-seeking agent in cancer patients with skeletal metastases
    Nilsson, S
    Balteskard, L
    Fosså, SD
    Westlin, JE
    Bruland, OS
    Larsen, RH
    Borch, KW
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S290 - S290
  • [5] Antitumor Activity of Novel Bone-seeking, α-emitting 224Ra-solution in a Breast Cancer Skeletal Metastases Model
    Juzeniene, Asta
    Bernoulli, Jenni
    Suominen, Mari
    Halleen, Jussi
    Larsen, Roy Hartvig
    ANTICANCER RESEARCH, 2018, 38 (04) : 1947 - 1955
  • [6] The palliative management of skeletal metastases in prostate cancer: Use of bone-seeking radionuclides and bisphosphonates
    Hamdy, NAT
    Papapoulos, SE
    SEMINARS IN NUCLEAR MEDICINE, 2001, 31 (01) : 62 - 68
  • [7] Phase I clinical trial exploring the alpha emitting radium-223 against skeletal metastases: blood clearance in patients with breast and prostate cancer
    Larsen, RH
    Borch, KW
    Aas, M
    Fossaa, SD
    Balteskard, L
    Traasdahl, E
    Hess, S
    Salberg, G
    Henriksen, G
    Schoultz, BW
    Nilsson, S
    Bruland, OS
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 285 - 285
  • [8] Alpha-emitting Radium-223: two years follow up from a randomized phase II study in patients with bone metastases from hormone refractory prostate cancer
    Nilsson, S.
    Franzen, L.
    Parker, C.
    Bolstad, B.
    Ramdahl, T.
    Thuresson, M.
    Bruland, O.
    EJC SUPPLEMENTS, 2009, 7 (02): : 412 - 412
  • [9] PB-212/BI-212-EDTMP-SYNTHESIS AND BIODISTRIBUTION OF A NOVEL BONE SEEKING ALPHA-EMITTING RADIOPHARMACEUTICAL
    HASSFJELL, SP
    HOFF, P
    BRULAND, OS
    ALSTAD, J
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1994, 34 (08): : 717 - 734
  • [10] Evaluation of bone-seeking novel radiotracer 68Ga-NO2AP-Bisphosphonate for the detection of skeletal metastases in carcinoma breast
    Averilicia Passah
    Madhavi Tripathi
    Sanjana Ballal
    Madhav Prasad Yadav
    Rajeev Kumar
    Frank Roesch
    Marian Meckel
    Partha Sarathi Chakraborty
    Chandrasekhar Bal
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 41 - 49
12345